Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Levels of Serum Resistin in Asthmatics as a Potential Marker of Systemic Inflammation and Disease State.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2006 by Wilford Hall Medical Center.
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
Wilford Hall Medical Center
ClinicalTrials.gov Identifier:
NCT00339703
First received: June 19, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given